Ultragenyx Pharmaceutical Insider Trades
NASDAQ: RAREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 28 · $3.81M
- Shares bought / sold
- 0 / 164.52K
- Net activity
- Net selling $3.8 million
Ultragenyx Pharmaceutical insider activity
Over the last 12 months, Ultragenyx Pharmaceutical insiders reported 52 transactions on SEC Form 4: 0 open-market purchases and 28 sales. Insiders bought $0 and sold $3.8 million worth of stock, for net insider selling of $3.8 million. The largest seller was KAKKIS EMIL D, with $1.2 million in reported sales.
The most recent filing shows Horn Howard (Chief Financial Officer) selling 7,066 shares at $15.27 on Oct 15, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RARE's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RARE insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 15, 2026 | Horn HowardChief Financial Officer | Sale | 7,066 | $107.90K | Form 4 |
| Sep 15, 2026 | Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | 1,283 | $17.41K | Form 4 |
| Sep 3, 2026 | Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | 161 | $2.25K | Form 4 |
| Aug 3, 2026 | Horn HowardChief Financial Officer | Sale | 4,696 | $117.02K | Form 4 |
| Aug 3, 2026 | Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | 1,900 | $47.35K | Form 4 |
| Jul 1, 2026 | Horn HowardChief Financial Officer | Sale | 4,698 | $155.64K | Form 4 |
| Jun 15, 2026 | Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | 1,899 | $46.75K | Form 4 |
| Jun 15, 2026 | Sanders Corazon (Corsee) D.Director | Sale | 2,000 | $50.10K | Form 4 |
| Jun 1, 2026 | Horn HowardChief Financial Officer | Sale | 4,653 | $110.60K | Form 4 |
| May 18, 2026 | SULIMAN SHEHNAAZDirector | Sale | 5,740 | $144.19K | Form 4 |
| May 14, 2026 | WELCH DANIEL GDirector | Award | 7,751 | — | Form 4 |
| May 14, 2026 | NARACHI MICHAELDirector | Award | 7,751 | — | Form 4 |
| May 14, 2026 | Sanders Corazon (Corsee) D.Director | Award | 7,751 | — | Form 4 |
| May 14, 2026 | Dunsire DeborahDirector | Award | 7,751 | — | Form 4 |
| May 14, 2026 | SULIMAN SHEHNAAZDirector | Award | 7,751 | — | Form 4 |
| May 14, 2026 | Fust Matthew KDirector | Award | 7,751 | — | Form 4 |
| May 14, 2026 | Ray AmritDirector | Award | 7,751 | — | Form 4 |
| May 5, 2026 | Crombez EricEVP and Chief Medical Officer | Sale | 344 | $8.59K | Form 4 |
| May 1, 2026 | Horn HowardChief Financial Officer | Sale | 4,683 | $116.61K | Form 4 |
| Apr 22, 2026 | Huizenga Theodore AlanSVP, Chief Accounting Officer | Award | 20,241 | — | Form 4 |
| Apr 16, 2026 | Crombez EricEVP and Chief Medical Officer | Award | 34,674 | — | Form 4 |
| Apr 16, 2026 | Harris ErikEVP & Chief Commercial Officer | Award | 28,895 | — | Form 4 |
| Apr 16, 2026 | Parschauer Karah HerdmanEVP and Chief Legal Officer | Award | 28,895 | — | Form 4 |
| Apr 16, 2026 | Horn HowardChief Financial Officer | Award | 34,674 | — | Form 4 |
| Apr 16, 2026 | Pinion John RichardSee Remarks | Award | 23,116 | — | Form 4 |
| Apr 16, 2026 | Huang Dennis KarlSee Remarks | Award | 23,116 | — | Form 4 |
| Apr 16, 2026 | KAKKIS EMIL DPresident & CEO | Award | 76,745 | — | Form 4 |
| Apr 1, 2026 | Horn HowardChief Financial Officer | Sale | 4,683 | $98.20K | Form 4 |
| Mar 10, 2026 | Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | 3,508 | $79.53K | Form 4 |
| Mar 6, 2026 | Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | 6,018 | $128.79K | Form 4 |
| Mar 3, 2026 | Horn HowardChief Financial Officer | Sale | 1,635 | $36.62K | Form 4 |
| Mar 2, 2026 | Crombez EricEVP and Chief Medical Officer | Sale | 7,029 | $160.26K | Form 4 |
| Mar 2, 2026 | Horn HowardChief Financial Officer | Sale | 3,119 | $70.30K | Form 4 |
| Mar 2, 2026 | Horn HowardChief Financial Officer | Sale | 5,290 | $120.61K | Form 4 |
| Mar 2, 2026 | Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | 1,632 | $37.21K | Form 4 |
| Mar 2, 2026 | Huizenga Theodore AlanSVP, Chief Accounting Officer | Tax withholding | 148 | $3.46K | Form 4 |
| Mar 2, 2026 | Huang Dennis KarlSee Remarks | Tax withholding | 999 | $23.37K | Form 4 |
| Mar 2, 2026 | Harris ErikEVP & Chief Commercial Officer | Sale | 10,539 | $240.29K | Form 4 |
| Mar 2, 2026 | Pinion John RichardSee Remarks | Sale | 10,029 | $228.66K | Form 4 |
| Mar 2, 2026 | Parschauer Karah HerdmanEVP and Chief Legal Officer | Sale | 8,135 | $185.48K | Form 4 |
| Mar 2, 2026 | KAKKIS EMIL DPresident & CEO | Sale | 54,404 | $1.24M | Form 4 |
| Mar 1, 2026 | Crombez EricEVP and Chief Medical Officer | Award | 11,643 | — | Form 4 |
| Mar 1, 2026 | Horn HowardChief Financial Officer | Award | 6,143 | — | Form 4 |
| Mar 1, 2026 | Huang Dennis KarlSee Remarks | Award | 11,137 | — | Form 4 |
| Mar 1, 2026 | Harris ErikEVP & Chief Commercial Officer | Award | 11,643 | — | Form 4 |
| Mar 1, 2026 | Pinion John RichardSee Remarks | Award | 11,137 | — | Form 4 |
| Mar 1, 2026 | Parschauer Karah HerdmanEVP and Chief Legal Officer | Award | 11,137 | — | Form 4 |
| Mar 1, 2026 | KAKKIS EMIL DPresident & CEO | Award | 71,177 | — | Form 4 |
| Feb 2, 2026 | Horn HowardChief Financial Officer | Sale | 3,061 | $72.12K | Form 4 |
| Jan 2, 2026 | Horn HowardChief Financial Officer | Sale | 3,150 | $71.95K | Form 4 |
| Dec 29, 2025 | Huizenga Theodore AlanSVP, Chief Accounting Officer | Sale | 85 | $2.92K | Form 4 |
| Dec 10, 2025 | Horn HowardChief Financial Officer | Sale | 3,081 | $112.09K | Form 4 |
| Oct 13, 2025 | Horn HowardChief Financial Officer | Sale | 7,942 | $250.25K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4